GR3033956T3 - Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof - Google Patents

Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Info

Publication number
GR3033956T3
GR3033956T3 GR20000401641T GR20000401641T GR3033956T3 GR 3033956 T3 GR3033956 T3 GR 3033956T3 GR 20000401641 T GR20000401641 T GR 20000401641T GR 20000401641 T GR20000401641 T GR 20000401641T GR 3033956 T3 GR3033956 T3 GR 3033956T3
Authority
GR
Greece
Prior art keywords
diagnosis
therapy
determination
methods
antibodies against
Prior art date
Application number
GR20000401641T
Other languages
Greek (el)
Inventor
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of GR3033956T3 publication Critical patent/GR3033956T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20000401641T 1994-11-04 2000-07-14 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof GR3033956T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002238A IT1276860B1 (en) 1994-11-04 1994-11-04 NATURAL ANTIBODIES AGAINST ALLOGENIC AND XENOGENIC PROTEINS AND METHODS FOR THEIR DETERMINATION
PCT/EP1995/004239 WO1996014340A1 (en) 1994-11-04 1995-10-30 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Publications (1)

Publication Number Publication Date
GR3033956T3 true GR3033956T3 (en) 2000-11-30

Family

ID=11369803

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401641T GR3033956T3 (en) 1994-11-04 2000-07-14 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Country Status (26)

Country Link
EP (1) EP0789716B1 (en)
JP (1) JPH10508591A (en)
KR (1) KR100426029B1 (en)
CN (1) CN1046737C (en)
AR (1) AR002243A1 (en)
AT (1) ATE192166T1 (en)
AU (1) AU690756B2 (en)
BR (1) BR9509556A (en)
CA (1) CA2204380A1 (en)
CZ (1) CZ288322B6 (en)
DE (1) DE69516534T2 (en)
DK (1) DK0789716T3 (en)
ES (1) ES2147617T3 (en)
FI (1) FI971879A (en)
GR (1) GR3033956T3 (en)
HU (1) HUT76880A (en)
IL (1) IL115862A (en)
IT (1) IT1276860B1 (en)
NO (1) NO972046D0 (en)
NZ (1) NZ295171A (en)
PL (1) PL181115B1 (en)
PT (1) PT789716E (en)
RU (1) RU2160445C2 (en)
TR (1) TR199501353A2 (en)
WO (1) WO1996014340A1 (en)
ZA (1) ZA959255B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283634B1 (en) * 1996-05-10 1998-04-23 Zetesis Spa A CYTOFLUORIMETRIC METHOD FOR THE DETERMINATION OF TUMOR ANTI-ANTIGEN ANTI-BODIES IN SERUM
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
IT201600127428A1 (en) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli NEW RECOMBINANT UK 114 PROTEIN IN STABLE POLYMER FORM FOR USE IN THERAPY, IN DIAGNOSTICS AND IN THE PREVENTION OF MALIGNE NEOPLASIA
IT201900022203A1 (en) * 2019-11-26 2021-05-26 Cusani Alberto Bartorelli PROTEIN UK 114 FROM SALMON FOR USE IN THERAPY, DIAGNOSTICS AND PREVENTION OF MALIGNANT NEOPLASIES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.

Also Published As

Publication number Publication date
BR9509556A (en) 1997-09-16
ES2147617T3 (en) 2000-09-16
KR970707161A (en) 1997-12-01
ITMI942238A1 (en) 1996-05-04
CN1166838A (en) 1997-12-03
IL115862A (en) 2001-06-14
NO972046L (en) 1997-05-02
NO972046D0 (en) 1997-05-02
DE69516534T2 (en) 2000-11-30
EP0789716A1 (en) 1997-08-20
JPH10508591A (en) 1998-08-25
ATE192166T1 (en) 2000-05-15
TR199501353A2 (en) 1996-06-21
PL319878A1 (en) 1997-09-01
PL181115B1 (en) 2001-05-31
AU690756B2 (en) 1998-04-30
RU2160445C2 (en) 2000-12-10
FI971879A0 (en) 1997-05-02
CA2204380A1 (en) 1996-05-17
NZ295171A (en) 1998-07-28
KR100426029B1 (en) 2004-07-31
EP0789716B1 (en) 2000-04-26
ZA959255B (en) 1996-05-29
CZ288322B6 (en) 2001-05-16
WO1996014340A1 (en) 1996-05-17
DK0789716T3 (en) 2000-10-09
DE69516534D1 (en) 2000-05-31
MX9703191A (en) 1997-07-31
PT789716E (en) 2000-09-29
CZ131497A3 (en) 1997-12-17
FI971879A (en) 1997-06-24
IT1276860B1 (en) 1997-11-03
HUT76880A (en) 1997-12-29
CN1046737C (en) 1999-11-24
AR002243A1 (en) 1998-03-11
ITMI942238A0 (en) 1994-11-04
IL115862A0 (en) 1996-01-31
AU3845395A (en) 1996-05-31

Similar Documents

Publication Publication Date Title
EE04377B1 (en) Weight modulators, their corresponding nucleic acids and proteins, and their use in diagnostics and therapy
EP0668052A3 (en) Ultrasonic diagnosis and treatment system.
AU4220596A (en) Medical technology process for measuring the blood flow in an organ, and means therefor
SI1007089T1 (en) Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis
EP0643131A3 (en) Device for sample collection and in vitro transport, mainly for diagnostic use.
EP0674933A3 (en) Air filter material, its use and its preparation.
SI0825178T1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
GR3025747T3 (en) Device for the culture of molluses, in particular of oysters.
EP0758226A4 (en) Red blood cell surrogate
EP0805161A4 (en) (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
PL337667A1 (en) Superficially acting antigens and proteins useful in diagnostic compositions and in preventing lymean borreliosis
AU1769697A (en) Diagnostic method for measuring the ammonia content in breath
IL122094A0 (en) In situ - generated solid radiation source based on tungsten188/rhenium188 and the use thereof
GR3033956T3 (en) Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
EE9800333A (en) Novel furanarylmethylidene derivatives, methods for their preparation and use in therapy
EP0461473A3 (en) Method and means for eliminating clouding in biological fluids
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
ZA941645B (en) Antibodies specifically reactive against human prostate specific antigen.
Oostindie Caraïbische dilemma's in een'stagnerend'dekolonisatieproces
IT242042Y1 (en) STERILE WADDING CONTAINER.
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
IL113347A (en) Brain endothelial cell protein and methods for its use
GB9621093D0 (en) Antigen for use in cancer therapy and diagnosis
GB9614416D0 (en) Antigen for use in cancer therapy and diagnosis
SI0717108T1 (en) Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees